VRN-071961: a potent EGFR kinase inhibitor active in Ex20Ins EGFR mutation-driven NSCLC Nov. 5, 2019 No Comments
KYM-003, potent and selective STAT3 degrader with strong antitumor activity in vivo Nov. 5, 2019 No Comments
Development of novel PRKACA inhibitors for the treatment of fibrolamellar carcinoma Nov. 5, 2019 No Comments
RP-7214: a novel DHODH inhibitor with oral activity in preclinical AML models Nov. 4, 2019 No Comments
NTS2-selective compounds with promising activity in preclinical models of pain Nov. 4, 2019 No Comments
Preclinical evaluation of highly potent caspase-cleavable docetaxel prodrug, MPD-03 Oct. 31, 2019 No Comments
Novel class I HDAC inhibitor R8 demonstrates efficacy both in vitro and in vivo Oct. 28, 2019 No Comments
Preclinical results presented of a gene therapy for the treatment of retinitis pigmentosa Oct. 28, 2019 No Comments
RSS